{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:40:01Z","timestamp":1785465601577,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2020.08.038","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T21:50:17Z","timestamp":1598478617000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome"],"prefix":"10.1016","volume":"196","author":[{"given":"Mario","family":"Bazzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullia","family":"Todros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Ardissino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Cardaropoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Montaruli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-0763","authenticated-orcid":false,"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.08.038_bb0005","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3109\/14767058.2013.773308","article-title":"Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system","volume":"26","author":"Martin","year":"2013","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.thromres.2020.08.038_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.16225","article-title":"Maternal risk factors and adverse birth outcomes associated with HELLP syndrome: a population-based study","author":"Lisonkova","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.thromres.2020.08.038_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2393-9-8","article-title":"The HELLP syndrome: clinical issues and management. A review","volume":"9","author":"Haram","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.thromres.2020.08.038_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10641955.2016.1218505","article-title":"Hemolysis, elevated liver enzymes, and low platelet syndrome: outcomes for patients admitted to intensive care at a tertiary referral hospital","volume":"36","author":"Gedik","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.thromres.2020.08.038_bb0025","article-title":"Prognostic factors of the efficacy of high-dose corticosteroid therapy in hemolysis, elevated liver enzymes, and low platelet count syndrome during pregnancy: a meta-analysis","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2020.08.038_bb0030","series-title":"Clinical guideline [CG107]","article-title":"Hypertension in pregnancy: diagnosis and management","author":"NICE","year":"2010"},{"key":"10.1016\/j.thromres.2020.08.038_bb0035","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 task force on hypertension in pregnancy","volume":"122","author":"Gynecologists ACoOa","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.thromres.2020.08.038_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.blre.2014.01.003","article-title":"Diagnosis and management of complement mediated thrombotic microangiopathies","volume":"28","author":"Cataland","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2020.08.038_bb0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0034-1376153","article-title":"Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches","volume":"40","author":"Riedl","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.08.038_bb0055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.08.038_bb0060","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1182\/blood-2008-03-144691","article-title":"Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"112","author":"Fakhouri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.08.038_bb0065","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0070","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3109\/14767058.2012.694923","article-title":"The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome","volume":"25","author":"Crovetto","year":"2012","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.thromres.2020.08.038_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14767058.2016.1189897","article-title":"Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know?","volume":"30","author":"Haram","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.thromres.2020.08.038_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2012.09.026","article-title":"Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review","volume":"166","author":"Abildgaard","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0085","first-page":"1029","article-title":"Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome","volume":"88","author":"Lattuada","year":"2003","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2020.08.038_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/bjh.12494","article-title":"ADAMTS13 deficiency in severe postpartum HELLP syndrome","volume":"163","author":"Pourrat","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0095","unstructured":"Tufano A, Coppola A, Maruotti GM, Martinelli P, Cerbone AM, Di Minno G. HELLP syndrome and its relation with the antiphospholipid syndrome. Blood Transfus. 2014; 12: 114\u2013118. doi:https:\/\/doi.org\/10.2450\/2013.0154-13."},{"key":"10.1016\/j.thromres.2020.08.038_bb0100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.semarthrit.2011.05.007","article-title":"HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies","volume":"41","author":"Appenzeller","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.thromres.2020.08.038_bb0105","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00007611-200093080-00005","article-title":"Leukocytosis is proportional to HELLP syndrome severity: evidence for an inflammatory form of preeclampsia","volume":"93","author":"Terrone","year":"2000","journal-title":"South. Med. J."},{"key":"10.1016\/j.thromres.2020.08.038_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jri.2006.07.002","article-title":"Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"73","author":"Molvarec","year":"2007","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10641955.2013.806538","volume":"32","author":"Simsek","year":"2013","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.thromres.2020.08.038_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.thromres.2020.08.038_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","article-title":"Complement and its receptors: new insights into human disease","volume":"32","author":"Holers","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement--their role in inflammation","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0135","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2005.05612.x","article-title":"The measurement and application of thrombin generation","volume":"130","author":"Baglin","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0140","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jth.12615","article-title":"Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome","volume":"12","author":"Cugno","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.038_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201ckidney disease: improving global outcomes\u201d (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2020.08.038_bb0150","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical Hemolytic uremic syndrome and C3 Glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0155","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standardisation Committee of the International Society on thrombosis and haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.038_bb0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jth.12764","article-title":"Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis: comment","volume":"13","author":"Cugno","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.038_bb0165","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molimm.2005.06.041","article-title":"Does complement factor B have a role in the pathogenesis of atypical HUS?","volume":"43","author":"Kavanagh","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0170","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"J\u00f3zsi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.08.038_bb0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.038_bb0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.thromres.2020.08.038_bb0190","first-page":"285","article-title":"Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration","volume":"21","author":"Duvvari","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.thromres.2020.08.038_bb0195","first-page":"342","article-title":"Molecular basis of familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"14","author":"Caprioli","year":"2003","journal-title":"Saudi J Kidney Dis Transpl."},{"key":"10.1016\/j.thromres.2020.08.038_bb0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Diseases EWPoCGiR. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12185-014-1655-2","article-title":"Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation","volume":"100","author":"Matsumoto","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2020.08.038_bb0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.08.038_bb0215","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.08.038_bb0220","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.bbmt.2017.05.013","article-title":"Acquired complement regulatory gene mutations and hematopoietic stem cell transplant-related thrombotic microangiopathy","volume":"23","author":"Ardissino","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.thromres.2020.08.038_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.thromres.2020.08.038_bb0230","doi-asserted-by":"crossref","unstructured":"O Derzsy Z, Proh\u00e1szka Z, Rig\u00f3 J Jr, F\u00fcst G, Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol. Immunol. 2010; 47: 1500\u20131506. doi:https:\/\/doi.org\/10.1016\/j.molimm.2010.01.021.","DOI":"10.1016\/j.molimm.2010.01.021"},{"key":"10.1016\/j.thromres.2020.08.038_bb0235","doi-asserted-by":"crossref","unstructured":"Holmes VA, Wallace JM. Haemostasis in normal pregnancy: a balancing act? Biochem. Soc. Trans.. 2005; 33 (Pt 2): 428\u2013432.","DOI":"10.1042\/BST0330428"},{"key":"10.1016\/j.thromres.2020.08.038_bb0240","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4187\/respcare.04339","article-title":"Relationship of circulating C5a and complement factor H levels with disease control in pregnant women with asthma","volume":"61","author":"Boh\u00e1cs","year":"2016","journal-title":"Respir. Care"},{"key":"10.1016\/j.thromres.2020.08.038_bb0245","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.kint.2015.12.003","article-title":"Diagnosis of complement alternative pathway disorders","volume":"89","author":"Angioi","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2020.08.038_bb0250","doi-asserted-by":"crossref","unstructured":"Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M. Complement activation and thrombotic Microangiopathies. Clin. J. Am. Soc. Nephrol.. 2019; 14: 1719\u20131732. https:\/\/doi:https:\/\/doi.org\/10.2215\/CJN.05830519.","DOI":"10.2215\/CJN.05830519"},{"key":"10.1016\/j.thromres.2020.08.038_bb0255","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.038_bb0260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.thromres.2020.08.038_bb0265","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820304862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820304862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:44:03Z","timestamp":1758735843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820304862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":53,"alternative-id":["S0049384820304862"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.038","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}